Zobrazeno 1 - 10
of 38
pro vyhledávání: '"S. K. Soloviev"'
Publikováno v:
Современная ревматология, Vol 16, Iss 6, Pp 12-19 (2022)
Lupus nephritis (LN) is the leading cause of death in systemic lupus erythematosus (SLE), so its early detection and treatment is of utmost importance. Features of the onset, clinical signs, certain morphological classes, as well as more aggressive t
Externí odkaz:
https://doaj.org/article/e13ef0e16c8043e6b722f2648904954a
Publikováno v:
Современная ревматология, Vol 16, Iss 5, Pp 13-21 (2022)
Objective: to identify clinical and immunological variants (phenotypes) of systemic lupus erythematosus (SLE) using cluster analysis.Patients and methods. The study included 400 patients with diagnosis of SLE according to the 2012 SLICC classificatio
Externí odkaz:
https://doaj.org/article/ca36e3a60d614569ba966e95e910ae9c
Publikováno v:
Научно-практическая ревматология, Vol 60, Iss 4, Pp 397-412 (2022)
Systemic lupus erythematosus (SLE) is a systemic autoimmune rheumatic disease of unknown etiology, characterized by hyperproduction of non-organ-specific autoantibodies to various components of the cell nucleus and the development of immune-inflammat
Externí odkaz:
https://doaj.org/article/3ee0980fc5bd4f169eec7bf5db81c127
Publikováno v:
Современная ревматология, Vol 16, Iss 1, Pp 77-83 (2022)
Glucocorticoids (GC) currently remain one of the most important components of the treatment of systemic lupus erythematosus (SLE). However, prolonged use of GC inevitably leads to the development of irreversible organ damage. It has been proven that
Externí odkaz:
https://doaj.org/article/bdc566f244a14a639b0e6d27bdc8c8af
Autor:
N. Yu. Nikishina, E. V. Ermolaeva, A. A. Mesnyankina, E. A. Aseeva, S. K. Soloviev, B. Sh. Isaeva, G. M. Koylubaeva, A. M. Lila
Publikováno v:
Современная ревматология, Vol 15, Iss 6, Pp 111-116 (2021)
Systemic lupus erythematosus (SLE) is a multisystem disease characterized by chronic inflammation and damage to vital organs and systems. Despite the great success achieved in the treatment of SLE, glucocorticoids (GC) remain one of the main methods
Externí odkaz:
https://doaj.org/article/c4d317a0adbd47aa8a0bf24ee80cd796
Publikováno v:
Современная ревматология, Vol 15, Iss 4, Pp 94-100 (2021)
Over the past 50 years the survival rate of patients with systemic lupus erythematosus (SLE) significantly improved, however, it is necessary to develop a new generation of drugs for the treatment of lupus nephritis (LN), the development of which is
Externí odkaz:
https://doaj.org/article/89a57bb52238467aa7734468e3227dbb
Publikováno v:
Современная ревматология, Vol 15, Iss 4, Pp 126-128 (2021)
On April 28, 2021, a meeting of the Council of Experts was held with the participation of the leading experts in the field of rheumatic diseases, approaches to the treatment of patients with systemic lupus erythematosus (SLE) were discussed. The issu
Externí odkaz:
https://doaj.org/article/15a14c3249814be0a131257f179ed9da
Autor:
E. L. Nasonov, T. V. Beketova, T. M. Reshetnyak, A. M. Lila, L. P. Ananieva, T. A. Lisitsyna, S. K. Soloviev
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 4, Pp 353-367 (2020)
Inflammation and coagulation are key basic mechanism of protection against all potentially pathogenic mechanical and biological factors targeting human organism from inner and outer environment. On the other hand, uncontrolled inflammation results in
Externí odkaz:
https://doaj.org/article/5d797047e36e4c3ba40a81315699f98d
Autor:
D. V. Bukhanova, B. S. Belov, G. M. Tarasova, S. K. Soloviev, L. P. Ananyeva, T. V. Popkova, A. V. Gordeev, Yu. V. Muravyov, S. I. Glukhova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 86-91 (2019)
Aim. Study of spectrum, frequency and risk factors of comorbid infections in rheumatic diseases (RD) in the stationary contingent of patients hospitalized in the FSBI RIR named after V.A. Nasonova within 1 year.Patients and methods. The study include
Externí odkaz:
https://doaj.org/article/bc9270019d754fe692000aa62d0f8e6a
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 2, Pp 218-221 (2019)
In recent years, the long-term survival of patients with systemic lupus erythematosus (SLE) has increased to more than 90%, but there are still quite a few unresolved problems. Although the main objective of the concept of «Treatment of SLE to targe
Externí odkaz:
https://doaj.org/article/e2c25b21429146c7bd494611b5d912c4